G Ackermann

1.4k citations

39 papers · 1.1k indexed · h-index 21

Impact in

Infectious Diseases top 2%
- Clostridium difficile and Clostridium perfringens research
- Antimicrobial Resistance in Staphylococcus
- Viral gastroenteritis research and epidemiology
Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria

Papers in ⓘ

Molecular Medicine 8
- Antibiotic Resistance in Bacteria 8
Infectious Diseases 20
- Clostridium difficile and Clostridium perfringens research 17
- Antimicrobial Resistance in Staphylococcus 10
- Viral gastroenteritis research and epidemiology 8

Co-authors: Arne C. Rodloff (17 shared papers)B. Löffler (3 shared papers)Reiner Schaumann (12 shared papers)Michael J. Gerber (2 shared papers)Marina C. Claros (3 shared papers)Ellie J. C. Goldstein (2 shared papers)Stuart H. Cohen (3 shared papers)Joseph Silva (2 shared papers)
Journals: Journal of Antimicrobial Chemotherapy (5 papers)Antimicrobial Agents and Chemotherapy (4 papers)Infection (4 papers)European Journal of Clinical Microbiology & Infectious Diseases (3 papers)Journal of Medical Microbiology (2 papers)
Partner nations: Germany United States Netherlands

In The Last Decade

G Ackermann

38 papers receiving 1.0k citations

Peers

Countries citing papers authored by G Ackermann

Since Specialization

Citations

This map shows the geographic impact of G Ackermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Ackermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Ackermann more than expected).

Fields of papers citing papers by G Ackermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Ackermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Ackermann. The network helps show where G Ackermann may publish in the future.

Co-authors

The 25 scholars most cited alongside G Ackermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with G Ackermann Line = papers co-authored together G Ackermann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Multidrug resistance in European Clostridium difficile clinical isolates Journal of Antimicrobial Chemotherapy ·Patrizia Spigaglia, Fabrizio Barbanti, Paola Mastrantonio, (unknown), G Ackermann, Carlo Balmelli, Frédéric Barbut, Emilio Bouza, J S Brazier, Michel Delmée, Denise Drudy, Ed J. Kuijper, H. Ladas, Edit Nagy, Hanna Pituch, Ian R. Poxton, Maja Rupnik, Marlene Wullt, M. Yücesoy	2011	149
2	Drugs of the 21st century: telithromycin (HMR 3647)--the first ketolide Journal of Antimicrobial Chemotherapy ·G Ackermann	2003	94
3	In Vitro Activity of OPT-80 against Clostridium difficile Antimicrobial Agents and Chemotherapy ·G Ackermann, B. Löffler, Daniela Adler, Arne C. Rodloff	2004	86
4	Resistance to Moxifloxacin in Toxigenic Clostridium difficile Isolates Is Associated with Mutations in gyrA Antimicrobial Agents and Chemotherapy ·G Ackermann, Yajarayma J. Tang, Robert Kueper, Peter Heisig, Arne C. Rodloff, Joseph Silva, Stuart H. Cohen	2001	59
5	Prevalence and association of macrolide-lincosamide- streptogramin B (MLSB) resistance with resistance to moxifloxacin in Clostridium difficile Journal of Antimicrobial Chemotherapy ·G Ackermann	2003	55
6	Comparative Activity of Moxifloxacin in Vitro Against Obligately Anaerobic Bacteria European Journal of Clinical Microbiology & Infectious Diseases ·G Ackermann, Reiner Schaumann, B. Pless, Marina C. Claros, Ellie J. C. Goldstein, Arne C. Rodloff	2000	55
7	Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile Journal of Medical Microbiology ·Michael J. Gerber, Christiane Walch, B. Löffler, Kristin Tischendorf, Udo Reischl, G Ackermann	2008	55
8	Antimicrobial phenotypes and molecular basis in clinical strains of Clostridium difficile Diagnostic Microbiology and Infectious Disease ·C. Schmidt, B. Löffler, G Ackermann	2007	47
9	Prevalence and characteristics of bacteria and host factors in an outbreak situation of antibiotic-associated diarrhoea Journal of Medical Microbiology ·G Ackermann, Susanne Thomalla, Frank Ackermann, Reiner Schaumann, Arne C. Rodloff, B. Ruf	2005	42
10	OPT-80, a macrocyclic antimicrobial agent for the treatment ofClostridium difficileinfections: a review Expert Opinion on Investigational Drugs ·Michael J. Gerber, G Ackermann	2008	39
11	Antecedent use of fluoroquinolones is associated with resistance to moxifloxacin in Clostridium difficile Clinical Microbiology and Infection ·G Ackermann, Yajarayma Tang-Feldman, Reiner Schaumann, Jeffrey P. Henderson, Arne C. Rodloff, J. Silva, Stanley Cohen	2003	39
12	Prevalence of Enterotoxin Producing Staphylococcus aureus in Stools of Patients with Nosocomial Diarrhea Infection ·Kerry Flemming, G Ackermann	2007	39
13	Infections Caused by Stenotrophomonas maltophilia - A Prospective Study Infection ·Reiner Schaumann, Kathy Stein, C. Eckhardt, G Ackermann, Arne C. Rodloff	2001	31
14	High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin Journal of Substance Abuse Treatment ·Michael Waizmann, G Ackermann	2010	27
15	Endothelial protection by defibrotide--a new strategy for treatment of myocardial infarction? PubMed ·Karsten Schrör, G Ackermann, T Hohlfeld, P Löbel, P Ney, H. Schröder, H. Strobach	1989	26
16	Mucosal-associated invariant T-Cell (MAIT) activation is altered by chlorpyrifos- and glyphosate-treated commensal gut bacteria Journal of Immunotoxicology ·Anne Mendler, Florian Geier, Sven‐Bastiaan Haange, Arkadiusz Pierzchalski, Jannike Lea Krause, Ivonne Nijenhuis, Jean Froment, Nico Jehmlich, Urs Berger, G Ackermann, Ulrike Rolle‐Kampczyk, Martin von Bergen�, Gunda Herberth	2020	24
17	In Vitro Activities of Gatifloxacin, Two Other Quinolones, and Five Nonquinolone Antimicrobials against Obligately Anaerobic Bacteria Antimicrobial Agents and Chemotherapy ·Reiner Schaumann, G Ackermann, B. Pless, Marina C. Claros, Arne C. Rodloff	1999	23
18	Isolation of Clostridium innocuum from cases of recurrent diarrhea in patients with prior Clostridium difficile associated diarrhea Diagnostic Microbiology and Infectious Disease ·G Ackermann, Yajarayma J. Tang, Spencer S. Jang, Joseph Silva, Arne C. Rodloff, Stuart H. Cohen	2001	21
19	In vitro activities of fourteen antimicrobial agents against obligately anaerobic bacteria International Journal of Antimicrobial Agents ·Reiner Schaumann, G Ackermann, B. Pless, Marina C. Claros, Ellie J. C. Goldstein, Arne C. Rodloff	2000	20
20	The Activation of Mucosal-Associated Invariant T (MAIT) Cells Is Affected by Microbial Diversity and Riboflavin Utilization in vitro Frontiers in Microbiology ·Jannike Lea Krause, Stephanie Serena Schäpe, Florian Schattenberg, Susann Müller, G Ackermann, Ulrike Rolle‐Kampczyk, Nico Jehmlich, Arkadiusz Pierzchalski, Martin von Bergen�, Gunda Herberth	2020	20

About G Ackermann

G Ackermann is a scholar working on Molecular Medicine, Infectious Diseases, Clinical Biochemistry, Critical Care and Intensive Care Medicine and Applied Microbiology and Biotechnology, having authored 39 papers that have together received 1.1k indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (17 papers), Antimicrobial Resistance in Staphylococcus (10 papers), Viral gastroenteritis research and epidemiology (8 papers), Antibiotic Resistance in Bacteria (8 papers), Microscopic Colitis (7 papers), Helicobacter pylori-related gastroenterology studies (7 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). The work is most often cited by research in Infectious Diseases (744 citations), Molecular Medicine (121 citations), Clinical Biochemistry (131 citations), Critical Care and Intensive Care Medicine (92 citations) and Applied Microbiology and Biotechnology (29 citations). G Ackermann has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Arne C. Rodloff, B. Löffler, Reiner Schaumann, Michael J. Gerber, Marina C. Claros, Ellie J. C. Goldstein, Stuart H. Cohen, Joseph Silva, Yajarayma J. Tang and Ed J. Kuijper. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, Infection, European Journal of Clinical Microbiology & Infectious Diseases and Journal of Medical Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact